CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 4 Open-market sale Director sold 5,436,673 shares at an average $0.55 ($3,009,262)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Exit or restructuring costs · Executive or director change · Other events
- 10-Q Report Quarterly Report
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
- 8-K Event Material agreement · Agreement ended
- 424B5 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other disposition Director disposed of 4,120,854 shares (other)
- 4 Derivatives Options or other derivatives
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 36 of 62 · 1,224 filings